Compositon useful for delivery of active agents
The invention provides a safe drug delivery composition that enhances the absolute bioavailability of active agent (drug).
1 . A powder composition comprising a mixture of a hydrophilic polymer matrix and a divalent inorganic metal compound, wherein the hydrophilic matrix comprises at least one synthetic polycarboxylated polymer.
2 . The composition of claim 1 wherein the metal is calcium or magnesium.
3 . The composition of claim 2 wherein the mixture comprises from about 0.5% to about 25% by wt of said divalent inorganic metal compound.
4 . The composition of claim 3 wherein said divalent inorganic metal compound is selected from the group consisting of CaCO 3 , Ca(OH) 2 , Mg(OH) 2 and mixtures thereof.
5 . The composition of claim 4 wherein the hydrophilic matrix comprises from about 5% by weight to about 95% by weight of said at least one synthetic polycarboxylated polymer and from about 5% by weight to about 95% by weight of at least one polysaccharide.
6 . The composition of claim 5 comprising from about 5% by weight to about 35% by weight of said at least one polysaccharide and from about 50% by weight to about 95% by weight of said at least one synthetic polycarboxylated polymer.
7 . The composition of claim 6 wherein the polysaccharide is a starch and the polycarboxylated polymer is a cross-linked poly(acrylic acid).
8 . The composition of claim 7 wherein the starch is a waxy starch.
9 . The composition of claim 3 further comprising an active agent.
10 . The composition of claim 9 wherein the active agent is a polypeptide.
11 . A method of producing a powder composition containing at least one synthetic polycarboxylated polymer component, at least one polysaccharide component, and at least one divalent inorganic metal compound, said method comprising preparing a solution comprising at least one solvent and a polymer mixture wherein the polymer mixture comprises at least one synthetic polycarboxylated polymer component and at least one polysaccharide component, and then drying the solution to form a solid comprising an intimate mixture of said components, wherein the said at least one divalent inorganic metal compound is added to the solution prior to drying and is part of said intimate mixture or is physically mixed with said intimate mixture following the drying thereof.
12 . The method of claim 11 further comprising adding an active ingredient, wherein the active ingredient is added to the solution prior to drying and becomes part of said intimate mixture or is physically mixing with said intimate mixture following the drying thereof.
13 . The method of claim 11 wherein said polymer mixture comprises, on a solids basis, from about 5% by weight to about 35% by weight of at least one polysaccharide and from about 50% by weight to about 95% by weight of at least one synthetic polycarboxylated polymer.
14 . The method of claim 11 wherein the solution is spray-dried.
15 . The method of claim 14 wherein the solvent is water, the polysaccharide is a starch and the polycarboxylated polymer is cross-linked poly(acrylic acid).
16 . A composition prepared by the method of claim 11 .
17 . An active component delivery vehicle comprising the composition of claim 1 and an active ingredient.
18 . The delivery vehicle of claim 17 wherein the composition comprises from about 75% by weight to about 99.5% by weight of said polymer matrix and from about 0.5% to about 25% by wt of said divalent inorganic metal compound, said polymer matrix comprising from about 75% by weight to about 95% by weight of a cross-linked poly(acrylic acid) and from about 5% by weight to about 25% by weight of a starch.
19 . A method of administering a therapeutic agent to an individual in need thereof comprising administering a drug delivery system comprising the composition of claim 1 and an active agent.
20 . The method of claim 19 wherein the composition comprises from about 75% by weight to about 99.5% by weight of said polymer matrix and from about 0.5% to about 25% by wt of said divalent inorganic metal compound, said polymer matrix comprising from about 75% by weight to about 95% by weight of a cross-linked poly(acrylic acid) and from about 5% by weight to about 25% by weight of a starch.
21 . The method of claim 20 wherein the composition is applied to a mucosal surface of the individual.
22 . The method of claim 21 wherein the composition is applied to the nasal mucosa.